Literature DB >> 19941387

Antigens containing TAVSPTTLR tandem repeats could be used in assaying antibodies to Classical swine fever virus.

Y Qi1, B Q Zhang, Z Shen, Y H Chen.   

Abstract

Classical swine fever virus (CSFV) causes a highly contagious and often fatal viral disease in pigs. The highly conserved epitope TAVSPTTLR on the glycoprotein E2 was shown to be suitable for differentiation of CSFV from other pestiviruses. In this study, we found that swine CSFV antisera contained TAVSPTTLR-related rather than TAVSPTTLR-specific CSFV antibodies. The CSFV antisera reacted only to some extent with a synthetic TAVSPTTLR-containing peptide, but inhibited the binding of TAVSPTTLR-specific antibodies to the viral antigen. Since chimeric antigens containing TAVSPTTLR tetramers or hexamers were recognized by the swine CSFV antisera, such antigens could be potentially applied to the detection of CSFV antibodies. These results might be helpful in designing a TAVSPTTLR epitope-based CSFV vaccine and a corresponding serological test.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941387     DOI: 10.4149/av_2009_04_241

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  3 in total

1.  Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture.

Authors:  Immanuel Leifer; Sandra Blome; Ulrike Blohm; Patricia König; Heike Küster; Bodo Lange; Martin Beer
Journal:  Vet Res       Date:  2012-04-20       Impact factor: 3.683

Review 2.  Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters.

Authors:  Fun-In Wang; Ming-Chung Deng; Yu-Liang Huang; Chia-Yi Chang
Journal:  Viruses       Date:  2015-06-29       Impact factor: 5.048

Review 3.  Complex Virus-Host Interactions Involved in the Regulation of Classical Swine Fever Virus Replication: A Minireview.

Authors:  Su Li; Jinghan Wang; Qian Yang; Muhammad Naveed Anwar; Shaoxiong Yu; Hua-Ji Qiu
Journal:  Viruses       Date:  2017-07-05       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.